Dr. Rubinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue
Boston, MA 02215Phone+1 617-632-4405Fax+1 617-632-5370- Is this information wrong?
Summary
- I am a board certified medical oncologist specializing in gastrointestinal malignancies.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2010 - 2014
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013
- Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
- Brigham and Women's HospitalInternship, Internal Medicine, 2007 - 2008
- Harvard Medical SchoolClass of 2007
Certifications & Licensure
- VT State Medical License 2022 - 2024
- MA State Medical License 2009 - 2024
- ME State Medical License 2023 - 2024
- RI State Medical License 2020 - 2020
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Closed-loop automated drug infusion regulator: A clinically translatable, closed-loop drug delivery system for personalized drug dosing.Louis B DeRidder, Kyle A Hare, Aaron Lopes, Josh Jenkins, Nina Fitzgerald, Emmeline MacPherson, Niora Fabian, Josh Morimoto, Jacqueline N Chu, Ameya R Kirtane, Wiam Ma...> ;Med. 2024 Apr 23
- RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Eliza...> ;Clinical Cancer Research. 2024 Apr 15
- Design and Implementation of an Opt-Out, End-to-End, PreemptiveTesting Program for Patients Planned for a Systemic Fluoropyrimidine.Garrett Rompelman, Angela Chen, Samantha Morrison-Ma, Lindsay Murray, Maria Ferzoco, Joseph O Jacobson, Craig Bunnell, Andrew J Wagner, Daniel Roberts, Jennifer Chan, ...> ;JCO Oncology Practice. 2024 Apr 12
- Join now to see all
Journal Articles
- Diabetes, Weight Change, and Pancreatic Cancer RiskDouglas A Rubinson, Kimmie Ng, Meir J Stampfer, Brian M Wolpin, JAMA Oncology
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Authored Content
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Join now to see all
Press Mentions
- A Closed-Loop Drug-Delivery System Could Improve ChemotherapyApril 25th, 2024
Professional Memberships
- Member
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: